A Message to the CHITREC Community Regarding Our COVID-19 Actions

Register by 11/30 for MU Public Health Registry Reporting

Eligible Providers must register their intent to submit to a public health registry within the first 60 days of their MU reporting period to meet MU Objective 10 Measure 3. Now, the Illinois Prescription Drug Monitoring (ILPMP) is a registry option. ILPMP has been approved as a specialized registry, regardless of whether an EP dispenses controlled substances/submits data to the registry.

EPs participating in MU may register intent to report to ILPMP and other Illinois Public Health registries in MURS within the first 60 days of their 2017 MU reporting period. If the registry you select isn’t yet collecting data you can provide, then registering with MURS is enough to satisfy a public health measure until the registry requests that EPs move forward with enrollment and EHR integration. If you are already registered, testing, or sending data to a registry for MU, you do not need to re-register in MURS.

Another resource that can be used as a specialized registry is the National Health Care Surveys. To see other options, view a list of approved registries.

 

 

Back to News

Chicago Health IT Regional Extension Center

625 N. Michigan Ave., 15th Floor
Chicago, IL 60611

Phone: 855-684-3571

Fax: 312-503-5775

Email: info@chitrec.org

© 2021 Northwestern University. Read our Terms of Use.
CHITREC is part of the Center for Health Information Partnerships (CHIP) in the Institute for Public Health and Medicine (IPHAM) at Northwestern University Feinberg School of Medicine.